Hemostatic Parameter Display

• US 20110252352A1
• Filed: 04/08/2011
• Published: 10/13/2011
• Est. Priority Date: 04/08/2010
• Status: Active Grant

• Current Assignee: Hemosonics LLC (Stago International SAS)
• Original Assignee: Hemosonics LLC (Stago International SAS)
• Inventors: Looker, Adam, Hansen, Bjarne, Browne, Gregory V., Roy, Bryan, Walker, William F., Viola, Francesco
• Granted Patent: US 10,147,152 B2
• Time in Patent Office: Days
• US Class Current: 715/771
• CPC Class Codes: A61B 5/14 Devices for taking samples of blood hypodermic syringes A61M5/00; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood measuring of blood pressure A61B5/02; non-radiation detecting or locating of foreign bodies in blood A61B5/06
• CPC Class Codes: A61B 5/1405 Devices for taking blood samples devices for taking samples of other body liquids A61B10/0045
• CPC Class Codes: A61B 5/1427 Multiple blood sampling, e.g. at periodic or pre-established intervals
• CPC Class Codes: A61B 5/150343 Collection vessels for collecting blood samples from the skin surface, e.g. test tubes, cuvettes sampling from within body cavities A61B5/150015, A61B5/150045
• CPC Class Codes: A61B 5/150755 Blood sample preparation for further analysis, e.g. by separating blood components or by mixing
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 15/00 ICT specially adapted for medical reports, e.g. generation or transmission thereof
• CPC Class Codes: G16H 40/60 for the operation of medical equipment or devices

Abstract

A system for displaying a plurality of hemostatic indexes is disclosed. The system includes a communication receiver configured to receive the hemostatic indexes and a graphical user interface (GUI) connected to the communication receiver and configured to simultaneously display the hemostatic indexes. The hemostatic indexes are derived from a plurality of independent measurements, such as the mechanical measurements determined using the sonorheometry systems and processes.

Claims

1. A system for displaying a hemostatic index, the system comprising:

a communication receiver configured to receive the hemostatic index; and

a graphical user interface (GUI) connected to the communication receiver and configured to display a hemostatic index;

wherein the hemostatic index is derived from a plurality of independent measurements.

2. A system of claim 1, wherein the communication receiver is configured to receive at least two hemostatic indexes and the GUI is configured to display the at least two hemostatic indexes simultaneously.

3. A system of claim 2, wherein at least one of the hemostatic indexes is derived from a combination of at least two of the independent measurements.

4. A system of claim 2, wherein each of the hemostatic indexes is derived from a corresponding one of the independent measurements.

5. A system of claim 2, wherein the independent measurement is a measurement of mechanical properties.

6. A system of claim 5, wherein the functional hemostasis indexes include at least one of a group consisting of a coagulation factor function, a fibrinogen concentration, a fibrinogen function, a platelet function and a fibrinolysis function.

7. A system of claim 6, wherein the functional hemostasis indexes include a numerical score.

8. A system of claim 6, wherein the functional hemostasis indexes include a graphical depiction.

9. A system of claim 6, wherein the coagulation factor function includes at least one of an intrinsic activation factor or an extrinsic activation factor.

10. A system of claim 6, wherein the GUI is further configured to display at least one of a group consisting of a hematocrit, hemoglobin concentration and red cell count.

11. A system of claim 10, wherein the GUI is further configured to display the at least one of the group consisting of the hematocrit, hemoglobin concentration and red cell count simultaneously with the at least two hemostatic indexes.

12. A system of claim 2, further comprising a consumable receptacle configured to receive a consumable holding at least two blood samples, wherein the blood samples are used to generate the independent measurements.

13. A system of claim 12, wherein each of the blood samples is used to generate a corresponding one of the independent measurements.

14. A system of claim 10, wherein the consumable receptacle is configured to position the at least two blood samples in a spatial arrangement corresponding to the display of the at least two hemostatic indexes.

15. A system of claim 12, wherein the corresponding spatial arrangement includes a side-by-side serial arrangement of both the blood samples and the hemostatic indexes.

16. A system of claim 2, wherein the GUI further comprises a visual element associating the display of each of the at least two hemostatic indexes with the at least two blood samples.

17. A system of claim 14, wherein the visual element includes at least one of lines or colors.

18. A system of claim 2, wherein the GUI is further configured to display a history of the hemostatic indexes.

19. A system of claim 18, wherein the GUI is further configured to display a clinical intervention overlaid on the history.

20. A system of claim 18, wherein at least one portion of the history includes an array of graphical indicators, each of the graphical indicators representing one of the hemostatic indexes at some time in the history.

21. A system of claim 20, wherein the graphical indicators have relative positioning configured to communicate a hemostatic condition of a subject.

22. A system of claim 2, wherein the GUI is further configured to display a treatment recommendation based on the at least two hemostatic indexes.

23. A system of claim 22, wherein the treatment recommendation is for guiding transfusion of at least one of platelets, cryoprecipitate, plasma, red cells or antifibrinolytics.

24. A system of claim 22, wherein the treatment recommendation is for guiding therapies of at least one of anti-platelet drug, anti-coagulant drug or pro-fibrinolysis drug.

25. A system of claim 2, wherein GUI is configured to display information for guiding transfusion or therapy.

26-48. -48. (canceled)